Berry Genomics - About the company
Berry Genomics is a public company based in Beijing (China), founded in 2010. It operates as a Provider of genetic testing products and tests. Berry Genomics has raised $16M in funding from Legend Capital. The company has 689 active competitors, including 73 funded and 77 that have exited. Its top competitors include companies like Natera, Strand Life Sciences and BGI.
Company Details
Biotech company that develops and commercializes next-generation sequencing based integrated solutions for clinical applications. Focuses majorly on genetic testing and oncology testing. It is one of the leading providers of non-invasive prenatal testing (NIPT) in China. Its products include NextSeq CN500 gene sequencing platform and supply of consumables to the sequencing system. In Dec 2016, the company went public on China's Shenzhen market via a reverse merger with Chengdu Tianxing Instrument & Meter, a shell auto company, in a deal that values Berry Genomics at $618.8M.
Get your free copy of Berry Genomics's company profile
Berry Genomics's funding and investors
Berry Genomics has raised a total funding of $16M over 3 rounds. Its first funding round was on 2011. Its latest funding round was a Series B round on Apr 02, 2015 for $16M. 1 investor participated in its latest round, which include Legend Star, Legend Capital, Qiming Venture Partners and CD Capital.
Berry Genomics has 8 institutional investors including Legend Capital, and Qiming Venture Partners.
Here is the list of recent funding rounds of Berry Genomics:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Apr 02, 2015 | $16M | Series B | 4981597 | 7988538 | |
Oct 2013 | Undisclosed | Series B | 4255483 | 5653719 | |
2011 | Undisclosed | Series A | 6876 | 8604 |
Access funding benchmarks and valuations. Sign up today!View details of Berry Genomics's funding rounds and investors
Access 秘密研究所 on any website
Our Google Chrome extension lets you view company details while browsing their websites
Berry Genomics's Competitors and alternates
Top competitors of Berry Genomics include Natera, Strand Life Sciences and BGI. Here is the list of Top 10 competitors of Berry Genomics, ranked by 秘密研究所 score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | 秘密研究所 Score |
|---|---|---|---|---|---|
1st | Natera 2004, Redwood City (United States), Public | Developer of cell-free DNA testing for oncology, women鈥檚 health, and organ health | $152M | 73/100 | |
2nd |  Strand Life Sciences 2000, Bengaluru (India), Acquired | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | $34.9M | 73/100 | |
3rd | Provider of services in genome sequencing | - | WinnerMax Capital, Yunfeng Capital听&补尘辫;听 | 59/100 | |
4th |  Source BioScience 1903, Nottingham (United Kingdom), Acquired | Provider of multiple genomic services | - | 59/100 | |
5th | _1551769784760.png?height=40&width=40){kind=logo} Rejuvenate Bio 2017, San Diego (United States), Series A | Developer of a gene-editing platform and anti-aging therapy for dogs | $14.6M | VCapital, Companion Fund听&补尘辫;听 | 59/100 |
6th | Provider of medical diagnosis and clinical laboratory analysis services | - | SVG Capital, BC Partners听&补尘辫;听 | 56/100 | |
7th | Beikang Medical 2010, Suzhou (China), Public | Developer of NGS-based diagnostic solutions for neonatal | $36.5M | Genesis Capital, Broad Vision Funds听&补尘辫;听 | 54/100 |
8th |  Progenity 2011, San Diego (United States), Public | Provider of non invasive prenatal genomic testing | $217M | 54/100 | |
9th | Novogene Corporation 2011, Beijing (China), Series B | Provider of genomic services and solutions | $75M | China Merchants Capital, 听&补尘辫;听 | 54/100 |
10th |  Enara Bio 2016, Oxford (United Kingdom), Series B | Developer of T-cell based cancer-cell interface for therapeutics | $84.1M | 53/100 | |
23rd | 2010, Beijing (China), Public | Provider of genetic testing products and tests | $16M | Legend Star, Legend Capital听&补尘辫;听 | 45/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Berry Genomics's competitors? Click to see the top ones
Berry Genomics's Investments and acquisitions
Berry Genomics has made no investments or acquisitions yet.
News related to Berry Genomics
Media has covered Berry Genomics for a total of 3 events in the last 1 year, 2 of them have been about company updates.
鈥�
cls.cn鈥�May 23, 2025鈥�Berry Genomics
鈥�
GlobeNewswire鈥�Jan 08, 2025鈥�Berry Genomics,
鈥�
cls.cn鈥�Dec 07, 2024鈥�Berry Genomics
鈥�
鈥�
鈥�
PEdaily鈥�Sep 05, 2021鈥�Sherpa Healthcare Partners, Innovent, Cytek Biosciences, Berry Genomics and 10 others
鈥�
36Kr鈥�Jul 12, 2021鈥�Berry Genomics
鈥�
鈥�
iYiou鈥�Jul 16, 2020鈥�Berry Genomics
鈥�
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQ's about Berry Genomics
Explore our recently published companies
- Tenevia - Meylan based, 2012 founded, Unfunded company
- Chat Diagram - Singapore based, 2024 founded, Unfunded company
- BuildQ - Sacramento based, 2024 founded, Unfunded company
